Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/20351| Title: | Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold. | Austin Authors: | Arulananda, Surein;Mitchell, Paul L R | Affiliation: | School of Cancer Medicine, La Trobe University, Heidelberg, Australia Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, University of Melbourne, Parkville, Australia Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Dec-2018 | Publication information: | Translational lung cancer research 2018; 7(Suppl 4): S388-S392 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/20351 | DOI: | 10.21037/tlcr.2018.08.12 | ORCID: | 0000-0002-5636-6381 | Journal: | Translational lung cancer research | PubMed URL: | 30705864 | ISSN: | 2218-6751 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.